Deferasirox and Vitamin D Improves Overall Survival in Elderly Patients with Acute Myeloid Leukemia after Demethylating Agents Failure

The prognosis of acute myeloid leukemia (AML) in elderly (≥65 years) patients is poor and treatment remains non-consensual especially for those who are not eligible for intensive therapies. Our group has shown that in vitro the iron chelator deferasirox (DFX) synergizes with vitamin D (VD) to promot...

Descripción completa

Detalles Bibliográficos
Autores principales: Paubelle, Etienne, Zylbersztejn, Florence, Alkhaeir, Sawsaneh, Suarez, Felipe, Callens, Céline, Dussiot, Michaël, Isnard, Françoise, Rubio, Marie-Thérèse, Damaj, Gandhi, Gorin, Norbert-Claude, Marolleau, Jean-Pierre, Monteiro, Renato C., Moura, Ivan C., Hermine, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688707/
https://www.ncbi.nlm.nih.gov/pubmed/23840388
http://dx.doi.org/10.1371/journal.pone.0065998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688707/
https://www.ncbi.nlm.nih.gov/pubmed/23840388
http://dx.doi.org/10.1371/journal.pone.0065998

Ejemplares similares